Posts

Featured image for patient-reported outcomes and AI in Pain Management

Integrated pain management is a specialty that has grown in recent years. Patient-reported outcomes and AI in pain management can provide insights to improve treatment plans. During each visit to a clinician, patients complete assessments to inform their provider about their current conditions. Each of these assessments creates a profile for the patient about their current and ongoing symptoms. Each of these patient-reported outcomes is extremely useful in tracking the success of a treatment plan. Recently, artificial intelligence (AI) has become an integral factor in learning more about these outcomes. AI can be trained to learn how different factors in a patient’s treatment plan affect their outcomes.

With pain management, it is essential to assess each patient’s pain symptoms frequently. By digitally recording responses to patient assessments, these patient-reported outcomes can be tracked more efficiently. To provide more effective treatment plans, pain management providers are using patient-reported outcomes and AI more often.

How does AI in healthcare work?

AI starts with compiling lots of data. In pain management, each time a patient visits their physician, they fill out assessments about their current symptoms and pain levels since their last visit. The provider then takes the information, compiles it, and compares it to each patient’s recent medication and lifestyle changes. In addition to this, the patient may utilize physical therapy or behavioral health resources in their treatment plan. All of these factors come into play when a provider makes decisions about the patient’s ongoing treatment will be. What has worked for them in the past? Are they improving? What else can they try?

This is where AI comes into play. AI and machine learning can take all of these factors and learn what can be an effective treatment plan for each patient. By compiling this data, AI can infer from previous assessments what is more or less likely to work for that patient based on their historical data.

AI recognizes patterns in treatment plans as data becomes available. Using this information can make a well-defined course of action for the healthcare provider. By utilizing these patient-reported outcomes and AI in pain management settings, treatment plans become more successful in pain patients.

Why is Pain Management a focus for AI?

Many different healthcare specialties can use AI with patient-reported outcomes. However, pain management tends to include a myriad of external factors for each patient. Pain management can include patients with medication dependencies, behavioral health diagnoses, and chronic diseases. Because of these factors, it is difficult to accurately weigh each one as a patient treatment plan is formed.

Because the opioid epidemic is a continuing concern for healthcare providers, AI has come into play more heavily. Digital healthcare has become a key player in combating the opioid crisis with remote patient monitoring and risk assessments. Correct dosing for opioid prescriptions is a fine line between addiction and chronic pain in patients. This is why AI has become prevalent in managing opioid use in hospital settings in recent years.

It’s also important to note that pain management is a very iterative an ongoing treatment process, and can differ greatly between patients. For this reason, collecting patient-reported outcomes to derive treatment options has proven to be successful in recent years.

How can I get started using AI in my practice?

cliexa’s pain management platform (cliexa-Ease) incorporates patient assessments and utilizes them to create a comprehensive risk score for each patient. The Symptom Severity Score (FIBR), Dallas Pain Questionnaire (DPS), Medical Outcomes Survey (MOS Core, SF-36), and Pain Disability Index (PDI) are all incorporated into the platform.

As a provider, you can create a risk matrix based on your treatment preferences and utilize this digital tool to streamline patient assessments and risk. Determining risk of a patient is the cornerstone to their treatment plan. Risk assessments assist the healthcare provider to make decisions based on many different factors that can affect a patient’s overall risk. Also, by tracking medication adherence and compliance with each patient will allow providers to better track their symptoms over time. All of these features are included in the cliexa-Ease platform and can help you to better track patient outcomes using remote monitoring and integrated risk assessments.

Learn more about cliexa’s digital platforms.

 

tracking the spread of COVID-19

The news of Coronavirus skyrocketing in China peaked during the month of January. At this time, the virus seemed so far away from our reality. Quickly, the virus has spread across the world. The testing for COVID-19 has become more advanced by the week and every day we see hundreds if not thousands more confirmed cases. Track the spread of COVID-19 here.

What can we do to prevent the spread of COVID-19?

As a healthy young individual, the most effective thing you can do is stay home and prevent the spread of this potentially deadly virus. Each citizen plays a large role in spreading the virus to others. The American population who are elderly or immunocompromised are at a higher risk for developing symptoms of the COVID-19 virus. Because of this, ALL citizens are at risk of spreading the virus and should take the quarantine seriously.

The CDC’s guidelines for how to prevent the spread of COVID-19 are conservative at this point. Wash your hands frequently and stay away from densely populated areas. This includes restaurants, bars, and stores. To bolster the prevention of the virus, counties in the San Francisco Bay area have placed a “shelter in place” order. Preventative measures like this will likely spread to other large cities in the coming days.

An important resource to note is the CDC’s guidelines for assessing risk in citizens that have potential exposure to the virus. Be sure to know the signs and symptoms of the virus and utilize any local drive-thru testing centers. Many hospitals are allowing at-risk citizens to call their hotline for remote screening of COVID-19. It’s important for citizens to stay up-to-date on recent news and be prepared to stay home in the coming weeks. As the spread of COVID-19 continues to ramp up in the US, it will be important that everyone does their part.

Work from home, avoid crowded areas, and prepare to stay home for at least the next three weeks. Preventing this virus starts with each individual making a choice to change their lifestyle for the better of their communities. The reason that China was able to reduce the spreading of COVID-19 is because they were willing to effectively quarantine.

How can we track the spread of COVID-19 more effectively?

Testing in the United States is slowly climbing. But, because of limited testing kits across the country, hospitals are being sure to utilize tests on only higher-risk citizens. As of now, people who have not been in direct contact with a confirmed case of Coronavirus are considered low-risk. However, citizens living in densely populated areas with high contact should assume that they have been exposed to the virus. Even if they are not tested, low-risk citizens should take all the same precautions as high-risk individuals to decrease the spread of COVID-19.

Digital healthcare technologies have been integral in tracking COVID-19. Here is how some tech companies are helping to control the spread of the virus. cliexa has incorporated the CDC’s risk assessment guidelines into a platform that can compile data and assess the risk of each patient that is worried about their exposure. This platform provides patient-reported data on risk and symptoms to physicians. This helps healthcare professionals better manage the amount of exposure cases across the nation. We are offering free demos of this platform. You can visit our contact page to schedule a time with our team to learn about the COVID-19 screening application offered through the cliexa platform.

 

cliexa CEO featured in #AskTheCEO podcast

cliexa’s CEO & Founder, Mehmet Kazgan, is featured in the #AskTheCEO Podcast! The #AskTheCEO Podcast host is Avrohom Gottheil, CEO of #AskTheCEO Media.

In this #AskTheCEO episode, Mehmet and Avrohom sit down and discuss the importance of artificial intelligence in healthcare. During the conversation, the two talk about the importance of utilizing innovative technology. This technology is essential in order to stay at the forefront of patient care. As diseases and viruses continue to evolve over time, new healthcare technologies give rise to revolutionary developments. Data collection and AI capabilities are now moving at a pace to evolve and keep up with new diseases and viruses around the world. It is up to the healthcare industry to utilize tools like cliexa in order to compile data and start improving patient outcomes.

cliexa allows for efficient tracking of data, allowing physicians to compile information and make better, more informed decisions on patient treatment plans. This is based on patient outcomes, symptoms, and treatment plans over time. This way, physicians can collect data on what treatments are more effective than others. They can also track patient medication management

Through AI capabilities, cliexa can help to predict optimized treatment plans based on past data collected. Now that cliexa is available on the Azure Marketplace, more physicians and healthcare systems can implement this technology. The Azure Marketplace offers digital platforms to improve healthcare efficiency for users. To learn more about cliexa’s capabilities and how they can benefit patients, physicians, and payors, contact us to schedule a demo here.

 

 

 

Image of the White House Lawn

cliexa’s hard work and commitment to improving our country’s healthcare systems has been recognized by the Office of American Innovation (OAI) for our advancements within the industry. The OAI, appointed by President Donald J. Trump, and led by Jared Kushner, has invited cliexa to attend the 2019 White House Blue Button Developers Conference in Washington, D.C. on Tuesday, July 30th at the Eisenhower Executive Office Building. We are humbled and honored to receive this invitation. We are looking forward to connecting and potentially collaborating with policymakers, technologists, and medical experts to advance the sharing of medical information through mobile technology.

We are one of the few technology vendors who have successfully enabled the Center for Medicare and Medicaid’s (CMS) Blue Button 2.0 API into our software platforms. According to CMS’s website, the Blue Button 2.0 API is a “developer-friendly, standards-based API that enables Medicare beneficiaries to connect their claims data to the applications, services and research programs they trust.” This API enables patients to sync their Medicare accounts to our applications and bi-directionally share the information, specifically claims data, to their providers, and care teams.

With this information, there are a variety of potential outcomes from leveraging this data, including streamlined documentation and the secure exchange of patient information which can lead to uncovering new insights about patients’ health status and increasing time for face-to-face interactions between patient and provider.

Image of cliexa-EASE with CMS' Blue Button 2.0 API enabled

Our first use case for this API was in our application, cliexa-EASE, designed for the Department of Health and Human ServicesAgency for Healthcare Research and Quality‘s Step-Up App Challenge. With this build, we were selected as one of the three winners of this challenge. The goal of the challenge was to develop an application that simplifies the process of collecting, interpreting, aggregating and sharing patient-reported outcomes (PRO) data related to physical function outcomes. Using the Blue Button 2.0 API, patients could connect Medicare accounts to our platform and share their claims data directly to the health systems’ electronic medical record system. Other functionalities including the connection and aggregation of data from IoT and wearable devices, electronic medical record systems paired with custom, mobile clinical assessments.

To learn more about the Blue Button 2.0 API, and the Blue Button Developers Conference, visit //bluebutton.cms.gov/

Image of the "Best Rheumatoid Arthritis Apps 2019" from Healthline Media
Image of the "Best Rheumatoid Arthritis Apps 2019" from Healthline Media

In a late May article by Healthline, cliexa-RA was named one of the “Best Rheumatoid Arthritis Apps of 2019.” For the second straight year, cliexa-RA has been nominated for this selection, receiving a perfect five stars on the iOS App Store and the highest average score among all apps named. With the extensive features, assessments, accuracy, and patient-physician efficiency included with the application, it is one of the most thorough rheumatoid arthritis apps on the market.

cliexa-RA is a specially designed app for tracking patient progress, medication adherence, and complications from the patient’s smartphone. It includes several medically validated and custom assessments for keeping tabs on patients and providing physicians with accurate and up-to-date information. The app can also use a patient’s medical history and statistical data to more clearly assess patients\’ rheumatoid arthritis progress and therefore help physicians accurately provide treatment plans. The outpatient data helps create efficiency of communication between patient and physician, cutting down on time spent at the clinic and providing more accurate care solutions.

cliexa’s platform implements effective Remote Patient Monitoring to optimize clinical workflow, medical billing compliance, and reimbursements. Accurate outpatient data is essential to the cliexa platform, with cliexa-RA being recognized for its capability to utilize Remote Patient Monitoring effectively.

Read More: The Best Rheumatoid Arthritis Apps of 2019

Previous: The Best Rheumatoid Arthritis Apps of 2018